US Patent 7560467 Indazolo-tetrahydropyrimidine-carboxamide derivative kinase inhibitors

Patent 7560467 was granted and assigned to Smithkline Beecham Limited on July, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Smithkline Beecham Limited

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7560467

Date of Patent

July 14, 2009

Patent Application Number

10560502

Date Filed

June 18, 2004

Patent Citations Received

‌

US Patent 11926596 Inhibitors of Rho associated coiled-coil containing protein kinase

Patent Primary Examiner

‌

Deepak Rao

Patent abstract

The present invention relates to indazolo-tetrahydropyrimidine-carboxamide derivatives, compositions and medicaments containing the same, as well as processes for the preparation and use of such compounds, compositions and medicaments. Such indazolo-tetrahydropyrimidine-carboxamide derivatives are useful in the treatment of diseases associated with inappropriate ROCK-1 kinase.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7560467 Indazolo-tetrahydropyrimidine-carboxamide derivative kinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API